BWAY
BrainsWay Ltd.
NASDAQ · ILHealthcareMedical - Devices
$16.50+4.90%
Price as of Jul 20, 2026
BWAY growth
BrainsWay Ltd. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +29.4%
- EBITDA
- +90.6%
- EBIT
- +206.9%
- EPS
- +182.0%
- Free cash flow
- +42.8%
- Operating cash flow
- +16.9%
Forward estimates
- Revenue
- +29.6%
- EBITDA
- —
- EPS
- -13.9%
Three-year CAGR
- Revenue
- +24.3%
- EBITDA
- +113.9%
- EBIT
- +210.8%
- Net income
- +161.3%
- EPS
- +365.1%
- Free cash flow
- +152.2%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.